We appreciate the contribution of
any information, which may be helpful to your collegues and parents of
children with ITP. For example:
• Published Articles about Immune Thrombocytopenic Purpura (ITP)
• Your Valued Medical opinion about ITP
• Clinical Observations and ITP treatments
• Information about your ITP research in progress or planned
• Results of your ITP research
|
Library of Articles
MMR Vaccine May Raise Risk of Blood Disorder
NEW YORK - 3/10/2008 (REUTERS): Results of a study suggest a link between Measles-Mumps-Rubella (MMR) vaccine given in the second year of life and an increased risk of immune thrombocytopenic purpura.
To continue reading about the MMR Study, click here...
http://www.reutershealth.com
ICIS Reports on ITP Activities
A standing room-only audience attended the December 4 breakfast meeting of the Intercontinental Childhood ITP Study Group (ICIS) in San Diego. Held to coincide with the 46th annual meeting of the American Society of Hematology (ASH), the ICIS Meeting attracted physicians, researchers, nurses and other medical professionals with an interest in ITP.
Dr. Thomas Kuhne opened the meeting with comments on ICIS studies, and Dr. Paul Imbach, who serves on the Medical Advisory Board of the ITP Foundation and is Principal Investigator with the ICIS, reported on the ICIS Board meeting. Biologist Juliet Fong discussed the status of the PARC-ITP (Pediatric and Adult Intercontinental Registry for Chronic ITP) Study.
To continue reading about the ICIS Group, click here...
http://www.itpfoundation.org/upload/articles/ICIS at ASH.revised.doc
Study Shows No Adverse Reactions to Increased Infusion Rate of IVIG Treatmenthttp://www.itpfoundation.org/upload/articles/Gamunex.ASH.December 2004.docRefractory Idiopathic Immune Thrombocytopenic Purpura in Children
Paul Imbach / University Children's Hospital , Bazel, Switzerlandhttp://www.itpfoundation.org/upload/articles/ITPF_Doc.pdfAnti-D Initially Stimulates an Fc-dependent Leukocyte Oxidative Burst and Subsequently Suppresses Erythrophagocytosis via Interleukin-1 Receptor Antagonist
Malini D. Coopamah, John Freedman, and John W. Semplehttp://www.itpfoundation.org/upload/articles/Anti-D.pdfBlood Disorder Doesn't Slow Down Princeton Youth
George Robinson / Kentucky New Erahttp://www.kentuckynewera.com/cgi-bin/view.cgi?/200407/17+stone07172004_sports.html+20040717+sportsOut for Blood: Maintaining a Supply of the Vital Fluid of Life Requires a Long Journey and Dedicated Work
Andrew Martel / The Winchester Starhttp://www.winchesterstar.com/TheWinchesterStar/040918/Area_BLood.aspWatchful Waiting for ITP?
RA Dershewitzhttp://www.itpfoundation.org/upload/articles/Watchful Waiting ITP.Journal Watch.pdfShort-Course, High Dose Steroids for ITP
Allan S. Brett, MDhttp://www.itpfoundation.org/upload/articles/Steroid ITP.Journal Watch.pdfNewly Diagnosed ITP -- Which Therapy is Best?
F. Bruder Stapleton, MDhttp://www.itpfoundation.org/upload/articles/Newly Diagnosed ITP.Journal Watch.pdfResponse to Intravenous Immunoglobulin Predicts Splenectomy Response in Children With Immune Thrombocytopenic Purpura
Derick Holt, Justin Brown, Kelly Terrill, Robert Goldsby, Rebecka L. Meyers, Jody Heximer, Beth Nordfors and William B. Slaytonhttp://www.itpfoundation.org/upload/articles/IVIG Splenectomy Response.ITP.pdfITP: The Bad Actors
Alan Lichtinhttp://www.itpfoundation.org/upload/articles/ITP Splenectomy Bad actors.pdfImmune Thrombocytopenic Purpura (ITP) Plasma and Purified ITP Monoclonal Autoantibodies Inhibit Megakaryocytopoiesis in Vitro
Mei Chang, Peggy A. Nakagawa, Shirley A. Williams, Michael R. Schwartz, Karen L. Imfeld, Jeffrey S. Buzby and Diane J. Nugent / Children's Hospital of Orange Countyhttp://www.itpfoundation.org/upload/articles/ITP Plasma.pdfIVIG Induces Dose-Dependent Amelioration of ITP in Rodent Models
Andrew R. Crow, Seng Song, John W. Semple, John Freedman, and Alan H. Lazarus / St Michael's Hospitalhttp://www.itpfoundation.org/upload/articles/IBIG amlerioration.pdfHelicobacter Pylori and Idiopathic Thrombocytopenic Purpura in Children
Jukka Rajantie and Timo Klemola / Helsinki University Centralhttp://www.itpfoundation.org/upload/articles/helicobacter pylori in children.ITP.pdfHelicobacter Pylori and ITP: Many Questions, Few Answers
Keith R. McCrae / Case Western Reserve University School of Medicinehttp://www.itpfoundation.org/upload/articles/helicobacter pylori.ITP.pdfThe Biology and Treatment of ITP: What's Next?
Steven E. McKenzie / Cardeza Foundation for Hematologic Researchhttp://www.itpfoundation.org/upload/articles/biology and treatment of ITP.pdfAntibodies Redux
Douglas B. Cines / University of Pennsylvaniahttp://www.itpfoundation.org/upload/articles/Antibodies Redux.pdfAnti-CD40L: Biology and Therapy in ITP
Joseph Schwartz and James B. Bussel / New York Blood Center and Weill Medical College of Cornell Universityhttp://www.itpfoundation.org/upload/articles/Ant-CD40L.ITP.pdfLong-Term Outcomes in Adults with Chronic ITP After Splenectomy Failure
Robert McMillan and Carol Durettehttp://www.itpfoundation.org/upload/articles/Adult ITP Splenectomy Failures.pdf |
The ITPF Gazette has arrived!
Click here to be placed on the mailing list free of charge, and start receiving the Official Newsletter of The ITP Foundation.
Remain up to speed on ITP medical research, the latest developments of the ITP Team, and future events of the ITPF. Also, read first hand accounts from those personally affected by ITP, and receive exclusive coupons to the ITPF Store.
Get your subscription today!
Join the ITP Team!
Compete in the races of your choosing to help The ITP Foundation spread awareness about ITP.
Learn more 
|